- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Limb-Girdle Muscular Dystrophy Type 2 in Korea, Republic of
Total 49 results
-
Cooperative International Neuromuscular Research...Carolinas Medical Center lead study siteCompletedBecker Muscular Dystrophy | Limb-Girdle Muscular Dystrophy, Type 2A (Calpain-3 Deficiency) | Limb-Girdle Muscular Dystrophy, Type 2B (Miyoshi Myopathy, Dysferlin Deficiency) | Limb-Girdle Muscular Dystrophy, Type 2I (FKRP-deficiency)United States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedBecker Muscular Dystrophy | Facioscapulohumeral Muscular Dystrophy | Limb-Girdle Muscular DystrophyUnited States
-
Cooperative International Neuromuscular Research...National Institutes of Health (NIH)CompletedDuchenne Muscular Dystrophy | Becker Muscular Dystrophy | Limb Girdle Muscular DystrophyUnited States
-
Cooperative International Neuromuscular Research...National Institutes of Health (NIH)CompletedDuchenne Muscular Dystrophy | Becker Muscular Dystrophy | Limb Girdle Muscular DystrophyUnited States
-
Cooperative International Neuromuscular Research...United States Department of DefenseCompletedDuchenne Muscular Dystrophy | Becker Muscular Dystrophy | Limb Girdle Muscular DystrophyUnited States, Japan, Canada
-
Yonsei UniversityCompletedSymptomatic Peripheral Artery Disease With Femoropopliteal Lesions | Moderate or Severe Claudication (Rutherford Category 2 or 3) | Critical Limb Ischemia (Rutherford Category 4 or 5)Korea, Republic of
-
Yonsei UniversityUnknownSymptomatic Peripheral Artery Disease With Femoropopliteal Lesions | Moderate or Severe Claudication (Rutherford Category 2 or 3) | Critical Limb Ischemia (Rutherford Category 4 or 5)Korea, Republic of
-
Boryung Pharmaceutical Co., LtdRecruitingType 2 Diabetes Mellitus | Essential HypertensionKorea, Republic of
-
Eulji University HospitalCompletedType 2 DiabetesKorea, Republic of
-
GuerbetCompletedType 2 Diabetes Mellitus | Coronary AtherosclerosisKorea, Republic of
-
Seoul St. Mary's HospitalCompletedCoronary Artery Disease | Cardiovascular Disease | Atherosclerosis | Asymptomatic Patients With Type 2 Diabetes MellitusKorea, Republic of
-
SanofiCompletedType 2 Diabetes MellitusKorea, Republic of
-
Yuhan CorporationCompletedType 2 Diabetes Mellitus | Atherosclerotic Cardiovascular DiseaseKorea, Republic of
-
Korea UniversityCompletedAtherosclerosis | Type 2 DiabetesKorea, Republic of
-
Boryung Pharmaceutical Co., LtdCompletedType 2 Diabetes Mellitus | Essential HypertensionKorea, Republic of
-
Seoul National University Bundang HospitalCompletedType 2 Diabetes Mellitus | Carotid AtherosclerosisKorea, Republic of
-
Korea UniversityWithdrawnAtherosclerosis | Type 2 DiabetesKorea, Republic of
-
Boryung Pharmaceutical Co., LtdRecruitingHypertension | Diabetes MellitusKorea, Republic of
-
Merck KGaA, Darmstadt, GermanyMerck Ltd.CompletedHypertension | Diabetes Mellitus, Type IIKorea, Republic of
-
Seoul National University Bundang HospitalSamjin Pharmaceutical Co., Ltd.Recruiting
-
Yuhan CorporationUnknownType 2 Diabetes | Atherosclerotic Cardiovascular DiseaseKorea, Republic of
-
Newcastle-upon-Tyne Hospitals NHS TrustJain FoundationActive, not recruitingDysferlinopathy | LGMD2B Now Classified as LGMDR2 | Miyoshi MyopathyKorea, Republic of, Chile, Spain, United States, Denmark, France, Italy, Japan, United Kingdom
-
AutotelicbioRecruitingDiabetes Mellitus, Type 2 | Essential HypertensionKorea, Republic of
-
Seoul National University Bundang HospitalCompletedHypertension | Diabetes Mellitus, Type 2 | Angiotensin/Renin/Aldosterone HypertensionKorea, Republic of
-
Chonbuk National University HospitalCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Seoul National University Bundang HospitalRecruitingHypertension | Diabetes Mellitus, Type 2 | Atherosclerosis | Renin HypertensionKorea, Republic of
-
AstraZenecaCompletedEffect of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol). (PATROL)Hypertension | Hyperlipidemia | GlycemiaKorea, Republic of
-
Kiyuk ChangSeoul St. Mary's Hospital; Pusan National University Hospital; Korea University... and other collaboratorsRecruitingMyocardial Infarction | Diabetes Mellitus, Type 2Korea, Republic of
-
Seoul National University Bundang HospitalDaewon Pharmaceutical Co., Ltd.RecruitingDiabetes Mellitus, Type 2 | Atherosclerosis | DyslipidemiaKorea, Republic of
-
Seoul National University Bundang HospitalKorea United Pharm. Inc.RecruitingDiabetes Mellitus, Type 2 | Atherosclerosis | DyslipidemiasKorea, Republic of
-
Chung-Ang UniversityUnknownDiabetes Mellitus, Type 2 | Acute Coronary SyndromeKorea, Republic of
-
Tehran University of Medical SciencesCompletedType 2 Diabetes Mellitus | Diabetic Nephropathy | Essential HypertensionIran, Islamic Republic of
-
AstraZenecaCompletedHypertensionKorea, Republic of
-
Baqiyatallah Medical Sciences UniversityCompletedDiabetes Mellitus, Type 2Iran, Islamic Republic of
-
Neurotech PharmaceuticalsThe Lowy Medical Research Institute LimitedCompletedMacular Telangiectasia Type 2United States, Australia
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesAustralia, United States, Canada, Mexico, Puerto Rico, Germany, Hungary, Ireland, Poland, Romania, Denmark, Czech Republic, India, Colombia, Finland, United Kingdom
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesMexico, Russian Federation, Spain, United States, Canada, Puerto Rico, Hungary, Peru, Romania, Poland, Germany, Czech Republic, India, Colombia, Denmark, Finland
-
Georgetown UniversityMerck Sharp & Dohme LLCTerminated
-
Boehringer IngelheimCompletedHypertension | Diabetes Mellitus, Type 2Taiwan, Korea, Republic of, United States, New Zealand, Australia, Argentina, Canada, Mexico
-
The George InstituteServierCompletedDiabetes Mellitus, Type 2Australia, Canada, China, Czech Republic, Estonia, France, Germany, Hungary, India, Ireland, Italy, Lithuania, Malaysia, Netherlands, New Zealand, Philippines, Poland, Russian Federation, Slovakia, United Kingdom
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, France, Spain, Sweden, China, Korea, Republic of, United States, Canada, Germany, Ireland, Mexico, Poland, India, Denmark, Hungary, United Kingdom, New Zealand, Malaysia, Netherlands, Russian Federation, Thailand, Romania, Ita... and more
-
GlaxoSmithKlineCompleted
-
Gilead SciencesCompletedCoronary Artery Disease | Type 2 Diabetes Mellitus | Angina PectorisCanada, Slovenia, United States, Israel, Germany, Georgia, Russian Federation, Czech Republic, Belarus, Bulgaria, Poland, Serbia, Slovakia, Ukraine
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2 | Acute Myocardial InfarctionCanada, Croatia, Czech Republic, Germany, Hungary, India, Israel, Lebanon, Poland, Romania, Russian Federation, Slovakia, Slovenia, South Africa, Spain, Turkey, United Kingdom
-
Recursion Pharmaceuticals Inc.RecruitingNeurofibromatosis Type 2United States
-
TakedaCompletedDiabetes Mellitus, Type 2 | Acute Coronary SyndromeUnited States, France, Italy, Poland, Ukraine, United Kingdom, Belgium, Germany, Hong Kong, Argentina, Chile, Colombia, Israel, Mexico, Portugal, Bulgaria, Malaysia, Romania, Serbia, South Africa, Japan, Canada, Finland, Taiwan, Korea,... and more
-
MorphotekNational Cancer Institute (NCI); Children's Oncology GroupCompletedUnspecified Childhood Solid Tumor, Protocol Specific | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedHIV Infection | Clear Cell Renal Cell Carcinoma | Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Chronic Myelomonocytic Leukemia | Juvenile Myelomonocytic Leukemia | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone... and other conditionsUnited States, Canada